#stocks#bullish#buys#analysts#research#WallStreet
$ACVA $BILI $CADL $MXCT $RLYB
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy if you can manage the risk.
These are all Buys if you can manage the risk.
Below are our Buys for Tuesday, 24 August, as follows:
ACV Auctions Inc. (NASDAQ:ACVA): Citigroup upgraded the stock to Buy from Neutral but dropped the target price to 23 from 29. The consensus target is 36.
Bilbili Inc. (NASDAQ:BILI): Goldman reiterated a Buy rating and cut its price target to 105 from $122. Shares traded in a 52-wk range of 40.40 – 157.66.
Candel Therapeutics Inc. (NASDAQ:CADL): UBS initiated coverage with a Buy rating and a 9 price target. Credit Suisse started it with an Outperform rating and a 15 price target, and Jefferies started it with a Buy rating and a 22 price target.
MaxCyte Inc. (NASDAQ:MXCT): Stifel initiated coverage with a Buy rating and an 18 price target. BTIG started it with a Buy rating and a 22 price target. The stock trades in a 52-wk range of 13.77 – 17.44.
Rallybio Corp. (NASDAQ:RLYB): Jefferies started coverage with a Buy rating and a 20 price target. Since the IPO, the shares have traded between 11.86 – 25.78
Have a prosperous day, Keep the Faith!
